Amyloid Arthropathy: A Review
- PMID: 34516450
- DOI: 10.1097/PAP.0000000000000317
Amyloid Arthropathy: A Review
Abstract
Amyloid arthropathy is a joint disease associated with systemic amyloidosis. Herein, we present a model case and review the clinicopathologic features and pathophysiology of this disorder. Amyloid arthropathy results from elevation of serum amyloidogenic proteins and their deposition as aggregates in synovial fluid and articular tissues. The most common proteins are beta-2-microglobulin in the context of long-term hemodialysis therapy and immunoglobulin light chains associated with plasma cell proliferations. We provide a comprehensive update on the pathogenesis, clinical manifestations, and pathologic features of amyloid arthropathy. We provide detailed insights on amyloid protein deposition and aggregation in joints and proper details for diagnosis.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Hawkins PN. The diagnosis, natural history and treatment of amyloidosis. The Goulstonian Lecture 1995. J R Coll Physicians Lond. 1997;31:552–560.
-
- Kyle RA. Amyloidosis: a convoluted story. Br J Haematol. 2001;114:529–538.
-
- Stone MJ. Samuel Wilks: the “grand old man” of British medicine. Proc (Bayl Univ Med Cent). 2010;23:263–265.
-
- Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–224.
-
- Husby G, Sletten K. Chemical and clinical classification of amyloidosis 1985. Scand J Immunol. 1986;23:253–265.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
